Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 12, 2013, Pages 1877-1884

  Shim, Sung Gon ^a   Jun, Dae Won ^a   Kim, Eun Kyung ^b   Saeed, Waqar Khalid ^a   Lee, Kang Nyeong ^a   Lee, Hang Lak ^a   Lee, Oh Young ^a   Choi, Ho Soon ^a   Yoon, Byung Chul ^a  

^a Hanyang University Medical Center   (South Korea)

^b Eulji University School of Medicine   (South Korea)

Author keywords

Adhesion; Caffeine; Liver fibrosis; Stellate cell; TGF

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CAFFEINE; CYCLIC AMP; F ACTIN; PROCOLLAGEN; PROCOLLAGEN TYPE IC; THIOACETAMIDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; ATTENUATION; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STELLATE CELL; SUPPLEMENTATION; WESTERN BLOTTING;

ADHESION; CAFFEINE; LIVER FIBROSIS; STELLATE CELL; TGF-Β;

ACTINS; ANIMALS; APOPTOSIS; CAFFEINE; CELL ADHESION; CELL LINE; CELL PROLIFERATION; CYCLIC AMP; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PEPTIDE FRAGMENTS; PROCOLLAGEN; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 84895828921     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12317     Document Type: Article

References (26)

1. Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005; 128: 24-32.
2. Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 2005; 129: 1928-1936.
3. Tanaka K, Tokunaga S, Kono S etal. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int. J. Epidemiol. 1998; 27: 438-443.
4. Larsson SC, Wolk A. Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology 2007; 132: 1740-1745.
5. Modi AA, Feld JJ, Park Y etal. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 2010; 51: 201-209.
6. Costentin CE, Roudot-Thoraval F, Zafrani ES etal. Association of caffeine intake and histological features of chronic hepatitis C. J. Hepatol. 2011; 54: 1123-1129.
7. Gressner OA, Lahme B, Siluschek M etal. Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells. Liver Int. 2009; 29: 886-897.
8. Huber WW, Rossmanith W, Grusch M etal. Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver. Food Chem. Toxicol. 2008; 46: 1230-1238.
9. Mascitelli L, Pezzetta F, Sullivan JL. Putative hepatoprotective effects of coffee. Aliment. Pharmacol. Ther. 2008; 27: 90-91; author reply 91-2.
10. Vitaglione P, Morisco F, Mazzone G etal. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 2010; 52: 1652-1661.
11. Lotersztajn S, Julien B, Teixeira-Clerc F etal. Hepatic fibrosis: molecular mechanisms and drug targets. Annu. Rev. Pharmacol. Toxicol. 2005; 45: 605-628.
12. Yang JI, Yoon JH, Bang YJ etal. Synergistic antifibrotic efficacy of statin and protein kinase C inhibitor in hepatic fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2010; 298: G126-132.
13. Bravi F, Bosetti C, Tavani A etal. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 2007; 46: 430-435.
14. Back SA, Craig A, Luo NL etal. Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury. Ann. Neurol. 2006; 60: 696-705.
15. Lv X, Chen Z, Li J etal. Caffeine protects against alcoholic liver injury by attenuating inflammatory response and oxidative stress. Inflamm. Res. 2010; 59: 635-645.
16. Gressner OA, Lahme B, Rehbein K etal. Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J. Hepatol. 2008; 49: 758-767.
17. Gressner AM, Weiskirchen R, Breitkopf K etal. Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 2002; 7: d793-807.
18. Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390: 465-471.
19. Cheng K, Yang N, Mahato RI. TGF-beta1 gene silencing for treating liver fibrosis. Mol. Pharm. 2009; 6: 772-779.
20. Schiller M, Dennler S, Anderegg U etal. Increased cAMP levels modulate transforming growth factor-beta/Smad-induced expression of extracellular matrix components and other key fibroblast effector functions. J. Biol. Chem. 2010; 285: 409-421.
21. Shin JW, Wang JH, Kang JK etal. Experimental evidence for the protective effects of coffee against liver fibrosis in SD rats. J. Sci. Food Agric. 2010; 90: 450-455.
22. Kim MO, Lee YJ, Han HJ. Involvement of Cx43 phosphorylation in 5′-N-ethylcarboxamide-induced migration and proliferation of mouse embryonic stem cells. J. Cell. Physiol. 2010; 224: 187-194.
23. Wang N, Feng Y, Lau EP etal. F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis Rhizoma on hepatoma cell migration. Integr. Cancer Ther. 2010; 9: 354-364.
24. Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit. Rev. Food Sci. Nutr. 2006; 46: 101-123.
25. Okano J, Nagahara T, Matsumoto K, Murawaki Y. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway. Basic Clin. Pharmacol. Toxicol. 2008; 102: 543-551.
26. Quan HY, Kim do Y, Chung SH. Caffeine attenuates lipid accumulation via activation of AMP-activated protein kinase signaling pathway in HepG2 cells. BMB Rep. 2013; 46: 207-212.